Menopause and Diabetes: How Menopause Affects Blood Sugar
9 minute read

Summary
Hormonal shifts during perimenopause and menopause lead to changes in body composition, increased visceral fat, and reduced insulin sensitivity, all of which can raise the risk of developing type 2 diabetes. These metabolic changes often occur independently of aging and may be accompanied by symptoms such as weight gain, fatigue, and disrupted sleep. Lifestyle interventions, hormone therapy, and targeted medications can help manage blood sugar and reduce diabetes risk during this transition. Early recognition and proactive management are key to supporting long-term health for women in midlife.
Menopause as a Metabolic Turning Point
Most of us know that menopause marks the end of the reproductive years, but we don’t often talk about how it also brings a lot of metabolic changes. Much of this comes back to estrogen and how it interacts with insulin and stores fat.
Specifically, even if their habits are the same as they’ve always been, many women notice more weight accumulating around their bellies during and after menopause. This type of fat, also known as visceral fat, is closely linked to inflammation and insulin resistance. On top of that, having lower estrogen levels can make the body less responsive to insulin, which then makes blood sugar harder to regulate.
Over time, these changes can lead to an increased risk of type 2 diabetes and heart disease.
While aging itself influences how efficient and healthy someone’s metabolism is, the hormonal changes of menopause create a distinct turning point. Another way to put it: Where women are in their menopausal transition may play a bigger role in their risk of developing metabolic issues than their ages do. And some research also shows that women who experience early menopause (when periods stop before age 45) have a higher risk of developing type 2 diabetes, probably because they’ve had lower estrogen levels for a longer period of time.
The upside is that there are plenty of ways to support your body through this change, and some of the health risks it may bring. Recognizing all these patterns is the first step to being more proactive, which might mean making lifestyle changes, getting medical support, or paying closer attention to early warning signs.
Hormonal Shifts: How Estrogen Loss Drives Metabolic Risk
Estrogen supports the body in lots of ways. To name a few, it’s involved in things like:
Insulin sensitivity
Maintaining lean muscle mass
Storing fat around the hips and thighs rather than the stomach area
Helping muscles absorb and use glucose from the blood
As estrogen levels ebb and flow during perimenopause and then stay low during menopause, that pattern changes. Abdominal fat increases while lean muscle gradually declines. At the same time, your body might respond less efficiently to insulin, meaning more insulin is needed to move glucose out of the bloodstream and into tissues. This can then contribute to higher fasting glucose and rising hemoglobin A1c levels.
And it’s not only estrogen that’s changing in midlife. Testosterone gradually falls, too. Together, these shifts further influence body composition, how much energy you have (which can make getting enough exercise harder), libido, appetite regulation, and glucose metabolism.
Long story short, all of the hormones that once helped buffer certain metabolic risks are no longer as protective.
How Menopause Increases Type 2 Diabetes Risk
So, we’ve covered how low estrogen levels can lead to more belly fat (aka visceral fat) as well as less lean muscle mass. But you might still be wondering how exactly that translates to an increased risk of type 2 diabetes.
Let’s start with the muscle component. Because muscle is a major site of glucose uptake, losing muscle can lower the body’s ability to clear sugar from the bloodstream efficiently. The result is worsening insulin resistance.
And then increased abdominal fat adds another layer of risk. Visceral fat, that deep belly fat that lines the internal organs, releases chemicals that increase inflammation and make the body less responsive to insulin. Over time, chronic low-grade inflammation can push glucose levels higher.
While estrogen’s metabolic effects are big culprits, other symptoms of menopause can indirectly contribute to the increased risk of weight gain and type 2 diabetes:
Sleep disruption — whether from night sweats or other reasons — affects cortisol and glucose regulation. It can also leave you feeling fatigued all day.
Chronic stress, fatigue, and mood changes can mess with eating patterns and motivation for working out.
Brain fog and difficulty concentrating are also common during menopause, and both can make simple things like making good eating choices or getting some steps in harder, too.
Insulin resistance, weight, and heart health are very connected, so cardiovascular risk can also rise within this environment.
The good news: Understanding that menopause raises baseline diabetes risk can help women monitor blood sugar and make healthy changes earlier instead of waiting until levels are high enough for a diagnosis.
The Role of Hormone Replacement Therapy (HRT) in Metabolic Health
Hormone replacement therapy (HRT), or menopause hormone therapy (MHT), helps relieve symptoms of menopause, including mood swings, vaginal dryness, sleep issues, and hot flashes. Some emerging science also shows that it might support metabolic function.
It works by supplementing estrogen to restore hormonal balance. For women who still have a uterus, progesterone is also prescribed to protect the uterine lining. Some studies show MHT could help with metabolic changes during menopause and lower the risk of type 2 diabetes by:
Improving insulin sensitivity in women who are post-menopause
Reduce the buildup of visceral fat
Addressing inflammation, which is also linked to type 2 diabetes
Large clinical trials have also shown that women with prediabetes who use MHT are less likely to develop type 2 diabetes compared with those who don’t. According to these studies, the effect seems strongest when women begin MHT treatment earlier along the menopausal transition (rather than waiting until after).
Even more, for women who already have type 2 diabetes, MHT may improve blood glucose control. That said, it’s not treated as a substitute for other standard diabetes treatments. Which is also to say, HRT isn’t usually prescribed solely to prevent diabetes. But for women who are experiencing vasomotor symptoms who are also concerned about their metabolic health, it can be one piece of a broader plan.
As always, timing, personal risk factors, and preferences all factor into the decision around treatment.
Choosing the Right HRT: Oral vs. Transdermal Options
MHT is an umbrella term for a range of treatments and forms. There are many ways to take it, with oral and transdermal (aka through the skin) being two of the most common.
Both oral and transdermal estrogen therapy are effective for managing many menopause symptoms and also show promise for helping with insulin sensitivity and body composition. The main difference lies in how the body processes them.
Oral Estrogen
Oral MHT is a great option for women who find taking a daily pill convenient and familiar.
This form of the medication is absorbed through the digestive system and processed by the liver before it goes into the bloodstream. That process can affect blood clotting, triglycerides (a type of fat), and certain inflammation markers.
This difference in absorption is important to talk through with a healthcare provider. For many healthy women, it’s a safe and effective option, but the liver “first-pass” effect is part of why risk profiles differ slightly from non-oral forms.
Transdermal Estrogen
Transdermal estrogen is also broken into a few subtypes. It can be absorbed through the skin via patches, gels, or sprays and can sometimes offer more flexible dosing. Since it enters the bloodstream directly, it doesn’t need to pass through the liver.
As a result, this form of MHT is associated with a lower risk of blood clots and may be a better fit for women with higher cardiovascular risk, obesity, or diabetes. Routine differences aside, that’s one of the main differences between oral and transdermal MHT.
A provider can help weigh all the factors and help you come up with a plan that balances the most relief and comfort with long-term safety.
Lifestyle Strategies to Complement HRT for Diabetes Prevention
Hormone therapy can improve symptoms and support your metabolism, but it works best alongside these healthy lifestyle habits:
Strength training and regular exercise. Resistance training helps preserve muscle mass, which gets more and more important as we age for everything from bone, glucose, heart, and mental health. Adding some cardio further supports heart health and lowers diabetes risk. When in doubt, shoot for a mix of both throughout the week, and start slow if you’re new to exercise or have been inactive for a while.
Dietary adjustments. A balanced diet of whole foods is extra important during menopause. Limiting processed foods, refined carbs, and added sugars is a great way to help stabilize blood sugar levels. You should also focus on getting enough protein to support muscles and fiber to support glucose absorption and improve satiety.
Better, high-quality sleep. Getting enough good sleep can support your hormones, blood sugar, and even make it easier to stick to healthy choices. If you’ve been having a hard time sleeping lately because of night sweats or other menopause symptoms, try changing your environment (hello, personal fans and bamboo sheets), limiting alcohol, and working on better sleep hygiene in general.
Stress management. Chronic stress elevates cortisol, which can raise blood sugar over time and lead to weight gain, partly because it messes with hunger hormones. Of course, this is much easier said than done, and what works for you could take some trial and error. Some techniques to check out: mindfulness meditation, breathwork, cognitive behavioral therapy, and good old-fashioned self-care.
Medical support (when appropriate). Simple lifestyle changes don’t work for everyone. In some cases, weight loss medications, like GLP-1 receptor agonists (such as Wegovy® and Ozempic®), can provide extra support on top of things like healthy eating and exercise, or in addition to MHT.
What to Discuss with Your Doctor: Shared Decision-Making for Metabolic Health
Whether in person or online, your visit will be most productive and helpful if you go in knowing what to talk about and ask. There’s a lot to keep track of and know, so let’s sum up how to approach the conversation:
Bring up your personal and family history. Diabetes, heart disease, high blood pressure, and clotting disorders all influence risk, so be sure to come prepared with this info.
Explore whether HRT makes sense for you. Depending on your situation and how much research you’ve done on MHT, you can ask them to go over everything from the best form for you to what the timing looks like, where you are in the transition, and your individual risk profile.
Find out if and how you should self-monitor your metabolic health. Ask about how you should track certain markers, like fasting glucose, hemoglobin A1c, cholesterol, blood pressure, and weight or body composition over time.
Ask for personalized lifestyle strategies. Clarify what changes would have the biggest impact on you personally based on your current habits and risk factors.
Be direct about whether additional tools are appropriate. There’s no shame in needing extra weight management support, and your provider is there to help. So don’t hesitate to ask if you’re a good fit for weight loss medications, or if they can give you a referral to a nutrition or exercise specialist.
Ultimately, the goal is to manage symptoms and improve day-to-day comfort while also protecting long-term health. Working with a menopause specialist who sees the whole picture can help you make informed decisions along the journey.
Frequently Asked Questions How does the loss of estrogen during menopause increase the risk of developing type 2 diabetes?
Estrogen plays a vital role in maintaining insulin sensitivity, preserving lean muscle mass, and directing fat storage toward the hips and thighs rather than the abdomen. As estrogen levels decline, the body becomes less responsive to insulin, requiring more of it to move glucose out of the bloodstream. This hormonal shift also leads to an increase in visceral fat and a decrease in muscle tissue. Because muscle is a primary site for glucose uptake and visceral fat releases inflammatory chemicals that drive insulin resistance, these combined changes can cause fasting glucose and hemoglobin A1c levels to rise.
What are the metabolic differences between oral and transdermal hormone replacement therapy?
The primary difference between these two forms of MHT is how the body processes the hormones. Oral estrogen is absorbed through the digestive system and processed by the liver before entering the bloodstream, which can influence blood clotting, triglycerides, and inflammation markers. Transdermal estrogen, delivered via patches, gels, or sprays, enters the bloodstream directly through the skin and bypasses the liver's first-pass effect. Because of this, transdermal options are associated with a lower risk of blood clots and may be a more appropriate choice for women with existing cardiovascular risks, obesity, or diabetes.
Can hormone replacement therapy help prevent metabolic issues in post-menopausal women?
Some research indicates that MHT may support metabolic function by improving insulin sensitivity, reducing the accumulation of visceral fat, and addressing inflammation linked to type 2 diabetes. Clinical trials have shown that women with prediabetes who use MHT are less likely to develop type 2 diabetes than those who do not, with the strongest effects seen in women who start treatment earlier in their menopausal transition. Additionally, for women who already have type 2 diabetes, MHT may help improve blood glucose control, though it is intended as a complement to standard diabetes treatments rather than a substitute.
Related Content
https://www.myalloy.com/blog/navigating-weight-shifts-in-perimenopause-and-menopause
https://www.myalloy.com/blog/perimenopausal-weight-gain-what-you-need-to-know
https://www.myalloy.com/blog/why-do-women-gain-weight-during-menopause
https://www.myalloy.com/blog/how-to-lose-weight-during-menopause
https://www.myalloy.com/blog/signs-and-symptoms-of-menopause-everything-you-need-to-know
https://www.myalloy.com/blog/what-types-of-menopause-treatments-can-help-my-symptoms
https://www.myalloy.com/blog/midlife-weight-gain-why-is-it-so-hard-to-lose
https://www.myalloy.com/blog/the-flash-in-the-heat-of-the-night
https://www.myalloy.com/blog/menopause-breast-cancer-and-what-comes-next
https://www.myalloy.com/blog/lesser-known-menopause-symptoms
https://myalloy.zendesk.com/hc/en-us/articles/25033598566035-How-does-Alloy-work
Citations
Irene Lambrinoudaki, Stavroula A Paschou, Eleni Armeni, Dimitrios G Goulis. The interplay between diabetes mellitus and menopause: clinical implications. Nat Rev Endocrinol 2022;18(10):608-622. PMID:35798847.
View sourceStavroula A Paschou, Panagiotis Anagnostis, Dimitra I Pavlou, Andromachi Vryonidou, Dimitrios G Goulis, Irene Lambrinoudaki. Diabetes in Menopause: Risks and Management. Curr Vasc Pharmacol 2019;17(6):556-563. PMID:29938620.
View sourceKate M Bermingham, Inbar Linenberg, Wendy L Hall, Kirstin Kadé, Paul W Franks, Richard Davies, et al.. Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study. EBioMedicine 2022;85:104303. PMID:36270905.
View sourceGuo-Qiang Zhang, Jin-Liang Chen, Ying Luo, Maya B Mathur, Panagiotis Anagnostis, Ulugbek Nurmatov, et al.. Menopausal hormone therapy and women's health: An umbrella review. PLoS Med 2021;18(8):e1003731. PMID:34339416.
View sourceKara L Marlatt, Dori R Pitynski-Miller, Kathleen M Gavin, Kerrie L Moreau, Edward L Melanson, Nanette Santoro, et al.. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring) 2022;30(1):14-27. PMID:34932890.
View sourceErin R Uddenberg, Nancy Safwan, Mariam Saadedine, Maria D Hurtado, Stephanie S Faubion, Chrisandra L Shufelt. Menopause transition and cardiovascular disease risk. Maturitas 2024;185:107974. PMID:38555760.
View sourceRyan M Hulteen, Kara L Marlatt, Timothy D Allerton, Dragana Lovre. Detrimental Changes in Health during Menopause: The Role of Physical Activity. Int J Sports Med 2023;44(6):389-396. PMID:36807278.
View source
Subscribe
Go ahead, you deserve to
feel fantastic
By subscribing you agree to our Terms of Service & Privacy Policy.